참고문헌
- Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996;335:909-918. https://doi.org/10.1056/NEJM199609263351301
- Masci E, Mariani A, Curioni S, Testoni PA. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis. Endoscopy 2003;35:830-834. https://doi.org/10.1055/s-2003-42614
- Cheon YK, Cho KB, Watkins JL, et al. Frequency and severity of post-ERCP pancreatitis correlated with extent of pancreatic ductal opacification. Gastrointest Endosc 2007;65:385-393. https://doi.org/10.1016/j.gie.2006.10.021
- Chen YK, Foliente RL, Santoro MJ, Walter MH, Collen MJ. Endoscopic sphincterotomy-induced pancreatitis: increased risk associated with nondilated bile ducts and sphincter of Oddi dysfunction. Am J Gastroenterol 1994;89:327-333.
- Freeman ML, Guda NM. Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc 2004;59:845-864. https://doi.org/10.1016/S0016-5107(04)00353-0
- Elmunzer BJ, Scheiman JM, Lehman GA, et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med 2012;366:1414-1422. https://doi.org/10.1056/NEJMoa1111103
- Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991;37:383-393. https://doi.org/10.1016/S0016-5107(91)70740-2
- Murray WR. Reducing the incidence and severity of post ERCP pancreatitis. Scand J Surg 2005;94:112-116. https://doi.org/10.1177/145749690509400206
- Dumonceau JM, Andriulli A, Deviere J, et al. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis. Endoscopy 2010;42:503-515. https://doi.org/10.1055/s-0029-1244208
- Nishijima MK, Takezawa J, Taenaka N, Shimada Y, Yoshiya I. Application of HPLC measurement of plasma concentration of gabexate mesilate. Thromb Res 1983;31:279-284. https://doi.org/10.1016/0049-3848(83)90330-4
- Cavallini G, Tittobello A, Frulloni L, Masci E, Mariana A, Di Francesco V. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography: gabexate in digestive endoscopy: Italian Group. N Engl J Med 1996;335:919-923. https://doi.org/10.1056/NEJM199609263351302
- Andriulli A, Leandro G, Niro G, et al. Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. Gastrointest Endosc 2000;51:1-7. https://doi.org/10.1016/S0016-5107(00)70377-4
- Andriulli A, Clemente R, Solmi L, et al. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. Gastrointest Endosc 2002;56:488-495. https://doi.org/10.1016/S0016-5107(02)70431-8
- Fujishiro H, Adachi K, Imaoka T, et al. Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study. J Gastroenterol Hepatol 2006;21:1065-1069. https://doi.org/10.1111/j.1440-1746.2006.04085.x
- Tsujino T, Komatsu Y, Isayama H, et al. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial. Clin Gastroenterol Hepatol 2005;3:376-383. https://doi.org/10.1016/S1542-3565(04)00671-8
- Ueki T, Otani K, Kawamoto K, et al. Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized trial. J Gastroenterol 2007;42:161-167. https://doi.org/10.1007/s00535-006-1986-8
- Yoo JW, Ryu JK, Lee SH, et al. Preventive effects of ulinastatin on post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a prospective, randomized, placebo-controlled trial. Pancreas 2008;37:366-370. https://doi.org/10.1097/MPA.0b013e31817f528f
- Abdel Aziz AM, Lehman GA. Pancreatitis after endoscopic retrograde cholangio-pancreatography. World J Gastroenterol 2007;13:2655-2668. https://doi.org/10.3748/wjg.v13.i19.2655
- Andriulli A, Caruso N, Quitadamo M, et al. Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study. JOP 2003;4:41-48.
- Vila JJ, Jimenez FJ, Prieto C, Borobio E, Juanmartinena JF, Borda F. Utility of bolus somatostatin administration in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a controlled, nonrandomized study. Gastroenterol Hepatol 2006;29:231-236. https://doi.org/10.1157/13085969
- Sternlieb JM, Aronchick CA, Retig JN, et al. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis. Am J Gastroenterol 1992;87:1561-1566.
- Binmoeller KF, Dumas R, Harris AG, Delmont JP. Effect of somatostatin analog octreotide on human sphincter of Oddi. Dig Dis Sci 1992;37:773-777. https://doi.org/10.1007/BF01296438
- Arcidiacono R, Gambitta P, Rossi A, Grosso C, Bini M, Zanasi G. The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy. Endoscopy 1994;26:715-718. https://doi.org/10.1055/s-2007-1009081
- Tulassay Z, Dobronte Z, Pronai L, Zagoni T, Juhasz L. Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography. Aliment Pharmacol Ther 1998;12:1109-1112. https://doi.org/10.1046/j.1365-2036.1998.00414.x
- Staritz M, Poralla T, Ewe K, Meyer zum Buschenfelde KH. Effect of glyceryl trinitrate on the sphincter of Oddi motility and baseline pressure. Gut 1985;26:194-197. https://doi.org/10.1136/gut.26.2.194
- Bang UC, Nojgaard C, Andersen PK, Matzen P. Metaanalysis: nitroglycerin for prevention of post-ERCP pancreatitis. Aliment Pharmacol Ther 2009;29:1078-1085. https://doi.org/10.1111/j.1365-2036.2009.03978.x
- Shao LM, Chen QY, Chen MY, Cai JT. Nitroglycerin in the prevention of post-ERCP pancreatitis: a meta-analysis. Dig Dis Sci 2010;55:1-7. https://doi.org/10.1007/s10620-008-0709-9
- Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction: Sildenafil Study Group. N Engl J Med 1998;338:1397-1404. https://doi.org/10.1056/NEJM199805143382001
- Galie N, Ghofrani HA, Torbicki A, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005;353:2148-2157. https://doi.org/10.1056/NEJMoa050010
- Fries R, Shariat K, von Wilmowsky H, Bohm M. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy. Circulation 2005;112:2980-2985.
- Eherer AJ, Schwetz I, Hammer HF, et al. Effect of sildenafil on oesophageal motor function in healthy subjects and patients with oesophageal motor disorders. Gut 2002;50:758-764. https://doi.org/10.1136/gut.50.6.758
- Cheon YK, Cho YD, Moon JH, et al. Effects of vardenafil, a phosphodiesterase type-5 inhibitor, on sphincter of Oddi motility in patients with suspected biliary sphincter of Oddi dysfunction. Gastrointest Endosc 2009;69:1111-1116. https://doi.org/10.1016/j.gie.2008.07.014
- Oh HC, Cheon YK, Cho YD, Do JH. Use of udenafil is not associated with a reduction in post-ERCP pancreatitis: results of a randomized, placebo-controlled, multicenter trial. Gastrointest Endosc 2011;74:556-562. https://doi.org/10.1016/j.gie.2011.04.047
- Prat F, Amaris J, Ducot B, et al. Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study. Gastrointest Endosc 2002;56:202-208. https://doi.org/10.1016/S0016-5107(02)70178-8
- Sand J, Nordback I. Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography. Digestion 1993;54:105-111. https://doi.org/10.1159/000201021
- Makela A, Kuusi T, Schroder T. Inhibition of serum phospholipase-A2 in acute pancreatitis by pharmacological agents in vitro. Scand J Clin Lab Invest 1997;57:401-407. https://doi.org/10.3109/00365519709084587
- Niederau C, Schulz HU. Current conservative treatment of acute pancreatitis: evidence from animal and human studies. Hepatogastroenterology 1993;40:538-549.
- Murray B, Carter R, Imrie C, Evans S, O'Suilleabhain C. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology 2003;124:1786-1791. https://doi.org/10.1016/S0016-5085(03)00384-6
- Cheon YK, Cho KB, Watkins JL, et al. Efficacy of diclofenac in the prevention of post-ERCP pancreatitis in predominantly high-risk patients: a randomized double-blind prospective trial. Gastrointest Endosc 2007;66:1126-1132. https://doi.org/10.1016/j.gie.2007.04.012
- van Hoogdalem EJ, de Boer AG, Breimer DD. Pharmacokinetics of rectal drug administration, part II: clinical applications of peripherally acting drugs, and conclusions. Clin Pharmacokinet 1991;21:110-128. https://doi.org/10.2165/00003088-199121020-00003
- van der Marel CD, Anderson BJ, Romsing J, Jacqz-Aigrain E, Tibboel D. Diclofenac and metabolite pharmacokinetics in children. Paediatr Anaesth 2004;14:443-451. https://doi.org/10.1111/j.1460-9592.2004.01232.x
- Deviere J, Le Moine O, Van Laethem JL, et al. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 2001;120:498-505. https://doi.org/10.1053/gast.2001.21172
- Morrow JB, Zuccaro G Jr, Conwell DL, et al. Sedation for colonoscopy using a single bolus is safe, effective, and efficient: a prospective, randomized, double-blind trial. Am J Gastroenterol 2000;95:2242-2247. https://doi.org/10.1111/j.1572-0241.2000.02308.x
- Sherman S, Cheng CL, Costamagna G, et al. Efficacy of recombinant human interleukin-10 in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in subjects with increased risk. Pancreas 2009;38:267-274. https://doi.org/10.1097/MPA.0b013e31819777d5
- Budzynska A, Marek T, Nowak A, Kaczor R, Nowakowska-Dulawa E. A prospective, randomized, placebocontrolled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis. Endoscopy 2001;33:766-772. https://doi.org/10.1055/s-2001-16520
- De Palma GD, Catanzano C. Use of corticosteriods in the prevention of post-ERCP pancreatitis: results of a controlled prospective study. Am J Gastroenterol 1999;94:982-985. https://doi.org/10.1111/j.1572-0241.1999.999_u.x
- Sherman S, Blaut U, Watkins JL, et al. Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study. Gastrointest Endosc 2003;58:23-29. https://doi.org/10.1067/mge.2003.307
- Toulon P, Chadeuf G, Bouillot JL, et al. Involvement of heparin cofactor II in chymotrypsin neutralization and in the pancreatic proteinase-antiproteinase interaction during acute pancreatitis in man. Eur J Clin Invest 1991;21:303-309. https://doi.org/10.1111/j.1365-2362.1991.tb01374.x
- Barkay O, Niv E, Santo E, Bruck R, Hallak A, Konikoff FM. Low-dose heparin for the prevention of post-ERCP pancreatitis: a randomized placebo-controlled trial. Surg Endosc 2008;22:1971-1976. https://doi.org/10.1007/s00464-007-9738-2
- Rabenstein T, Fischer B, Wiessner V, et al. Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis. Gastrointest Endosc 2004;59:606-613. https://doi.org/10.1016/S0016-5107(04)00159-2
피인용 문헌
- Endoscopic papillectomy, single-centre experience vol.28, pp.11, 2014, https://doi.org/10.1007/s00464-014-3596-5
- Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial vol.15, pp.None, 2015, https://doi.org/10.1186/s12876-015-0314-2
- Oral udenafil and aceclofenac for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a randomized multicenter study vol.30, pp.5, 2013, https://doi.org/10.3904/kjim.2015.30.5.602
- The effect of prophylactic peripapillary administration of methylprednisolone in reducing the risk and severity of postendoscopic retrograde cholangiopancreatography pancreatitis: A double blind clini vol.20, pp.9, 2013, https://doi.org/10.4103/1735-1995.170599
- Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis vol.29, pp.3, 2013, https://doi.org/10.1097/meg.0000000000000787
- Post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review for prevention and treatment vol.25, pp.29, 2013, https://doi.org/10.3748/wjg.v25.i29.4019